DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2020

	March 31, 2020
Stock options outstanding		1,181,309
Deferred share units outstanding		21,183
Shares available for grant under the DiaMedica Therapeutics Inc. Omnibus Incentive Plan		1,363,700
Common shares issuable under common share purchase warrants		255,000
Total		2,821,192